Design Therapeutics Inc (DSGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $670.46M
Last updated: Nov 17, 2026 at 4:33 PM ET
Design Therapeutics Inc (DSGN) Stock Chart
Design Therapeutics (DSGN) has a latest price of $9.84 on Nov 17, 2026, 43.0% below its 52-week high of $17.25. Its price rose 33.5% over the past 12 months. The month-end price fell 31.9% over the 5 years through Oct 2026, a compound annual decline of 7.4%.
Price Chart
From Mar 2021 to Oct 2026, its highest month-end close was $29.90 in Mar 2021 and its lowest $2.04 in Oct 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DSGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DSGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 38.3%, and over 6 months it fell 6.2%. The month-end price rose 423.5% over the 3 years through Oct 2026, a compound annual rate of 73.6%.
| Period | Change |
|---|---|
| 1 month | -7.5% |
| 3 months | -38.3% |
| 6 months | -6.2% |
| 12 months | +33.5% |
| 12 months, with dividends | +33.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +423.5% | +73.6% |
| 5 years | -31.9% | -7.4% |
Price by Year
Its best calendar year was 2024, when the price rose 132.8%, and its weakest was 2023, when it fell 74.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.68 | +13.9% |
| 2025 | $9.38 | +52.0% |
| 2024 | $6.17 | +132.8% |
| 2023 | $2.65 | -74.2% |
| 2022 | $10.26 | -52.1% |
Trading Range
The price is 14.2% below its 50-day average of $11.48 and 19.2% below its 200-day average of $12.18.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.84 | |
| 52-week high | $17.25 | -43.0% |
| 52-week low | $7.25 | +35.7% |
| 50-day average | $11.48 | -14.2% |
| 200-day average | $12.18 | -19.2% |
Price Risk
Over 3 years, its largest fall from a peak was 62.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.33 |
| Largest fall, 1 year | -39.3% |
| Largest fall, 3 years | -62.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DSGN
What is DSGN's 1-year price change?
Design Therapeutics's price rose 33.5% over the past 12 months. With dividends included, the 12-month total return was 33.5%.
What is DSGN's 5-year price change?
Design Therapeutics's month-end price fell 31.9% over the 5 years through Oct 2026, a compound annual decline of 7.4%. These figures leave out dividends.
What is DSGN's 52-week high and low?
Design Therapeutics's 52-week high is $17.25 and its 52-week low is $7.25. Its latest price of $9.84 on Nov 17, 2026 is 43.0% below the high.
What is DSGN's beta?
Design Therapeutics's 1-year beta against the S&P 500 is 1.33, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 39.3%.
Is the DSGN chart free?
Yes. Advanced Charting for DSGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DSGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors